Skip to main content

The Global Orthopedic Imaging Market Continues To Grow Owing To the High Prevalence of the Geriatric Population in the World

 


Market Overview:

X-rays, CT scans, and MRIs are the most commonly used imaging techniques in orthopedics. They are used to diagnose joint dislocations, fractures, and other bone conditions. They are also used to determine the cause of pain in joints and soft tissues. These imaging methods are essential for diagnosing orthopedic disorders and can help to determine treatment options and recovery. Musculoskeletal studies are performed by most radiologists. These tests give detailed visualization of the soft tissue anatomy. They can also be used to detect and diagnose arthritis and tendonitis. Musculoskeletal imaging is especially important in diagnosing real-time tendon pain. This information is useful for orthopedic physicians to help patients recover faster. It can also help them diagnose osteoarthritis, hip and pelvic problems, and other joint disorders.

Competitive Landscape:

Major players operating in the global orthopedic imaging market include Toshiba Corporation, EOS Imaging, Planmed OY, Koninklijke Philips N.V., Hitachi Ltd., Esaote SpA, Siemens AG, and GE Healthcare.

Key Market Drivers:

The increasing prevalence of the geriatric population in the world is expected to augment the growth of the global orthopedic imaging market. For instance, according to the United Nations, in 2019, there were around 703 million individuals aged 65 years or over in the world. X-rays are the most common type of orthopedic imaging. These scans use radioactive material to create images of bones. Digital X-rays are more accurate than traditional film X-rays and use less radiation. X-rays are also useful in diagnosing joint dislocations, fractures, and osteonecrosis. They can be used to detect other disorders, including tumors. X-rays are also used to determine the cause of osteoporosis, which is caused by decreased bone density. Moreover, the high prevalence of orthopedic care centers in the world is estimated to enhance the growth of the global orthopedic imaging market.

Covid-19 Impact Analysis:

During the COVID-19 pandemic, there have been several developments in the global orthopedic imaging market. For instance, in March 2022, Lokmanya Hospital and SRV Hospitals of India partnered in order to introduce an advanced Centre of Excellence in Robotic Orthopedics.

Key Takeaways:

·         North America is expected to dominate the growth of the global orthopedic imaging market, owing to the high prevalence of orthopedic hospitals in the United States. For instance, according to the U.S. News & World Report, there are around 1670 specialty orthopedic hospitals in the United States.

·         The Asia Pacific is estimated to witness high growth in the global orthopedic imaging market, owing to the high incidence of geriatric population in the region. For instance, according to The Japan Times, around 15% of the total population in Japan is aged over 75 years.

 

Comments

Popular posts from this blog

Fc Protein and Glycoengineered Antibodies Market Is Booming Worldwide 2023-2028

  Global Fc Protein and Glycoengineered Antibodies Market Drivers Key players in the market are focusing on research and development activities and receiving approvals from regulatory bodies, which are expected to boost the global Fc protein and glycoengineered antibodies market growth over the forecast period. For instance, in 2016, Genentech Inc. received approval from the U.S. Food and drug Administration (U.S. FDA) for Tecentriq (Atezolizumab). It is being used for the treatment of urothelial carcinoma. In March 2019, Tecentriq received its second approval from the U.S. FDA for the treatment of small lung cancer. Furthermore, in November 2017, TG Therapeutics, Inc. began its clinical trial of Ublituximab for the treatment of multiple sclerosis. It is currently in third phase of its clinical trial. Factors such as increasing product approvals and robust pipeline are expected to drive the global fc protein and glycoengineered antibodies market growth.  Increasing preva...

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

  A  biologic  drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms.  Biologic  drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket . 

Breathalyzers Market Development Analysis Contributing Top Vendor Landscape and Economic Growth 2028

  The breathalyzer market refers to the sales and distribution of devices used for measuring blood alcohol content (BAC) through analysis of a breath sample. These devices are widely used by law enforcement agencies for detecting drunk drivers and in workplaces for alcohol screening. The market has been growing due to increasing awareness about the dangers of drunk driving, stricter laws and penalties, and advancements in technology that have made breathalyzers more portable and user-friendly. The market is expected to continue growing in the future as demand for personal and professional use breathalyzers increases. Breathalyzers are instruments used for testing blood alcohol levels through an individual’s breath. These devices find application in probation departments, police departments, remand homes, and commercial sector. The global breathalyzers market is estimated to account for  US$ 6,384.5 Mn  in terms of value in 2020 and is expected to reach  US$ 71,8...